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The small GTPases Ras and Rap1 
bind to and control TORC2 activity
Ankita Khanna1,*, Pouya Lotfi2,*, Anita J. Chavan2, Nieves M. Montaño2, Parvin Bolourani3, 
Gerald Weeks3, Zhouxin Shen4, Steven P. Briggs4, Henderikus Pots1, Peter J. M. Van Haastert1, 
Arjan Kortholt1 & Pascale G. Charest2
Target of Rapamycin Complex 2 (TORC2) has conserved roles in regulating cytoskeleton dynamics and 
cell migration and has been linked to cancer metastasis. However, little is known about the mechanisms 
regulating TORC2 activity and function in any system. In Dictyostelium, TORC2 functions at the 
front of migrating cells downstream of the Ras protein RasC, controlling F-actin dynamics and cAMP 
production. Here, we report the identification of the small GTPase Rap1 as a conserved binding partner 
of the TORC2 component RIP3/SIN1, and that Rap1 positively regulates the RasC-mediated activation 
of TORC2 in Dictyostelium. Moreover, we show that active RasC binds to the catalytic domain of TOR, 
suggesting a mechanism of TORC2 activation that is similar to Rheb activation of TOR complex 1. Dual 
Ras/Rap1 regulation of TORC2 may allow for integration of Ras and Rap1 signaling pathways in directed 
cell migration.
The migration of cells in response to chemical signals (chemotaxis) is central to normal physiology and is involved 
in many pathological conditions, such as cancer cell metastasis. The Target of Rapamycin Complex 2 (TORC2) 
recently emerged as a key, conserved player in chemotaxis1. TOR complex 1 (TORC1) and TORC2 are conserved 
complexes formed by the serine/threonine kinase TOR. TORC1 is a master regulator of cell growth and its bio-
chemistry and regulation is well understood2. TORC2 plays evolutionarily conserved roles in controlling F-actin 
organization, and is involved in the regulation of various processes, including cell survival, protein synthesis, and 
metabolism3,4. However, in contrast to TORC1, little is understood as to how TORC2 is regulated in any system. 
Studies performed in Dictyostelium, a widely used model of eukaryotic chemotaxis, suggest that TORC2 acts as an 
integrator of cell movement and chemoattractant signal relay (when stimulated cells transmit chemoattractants 
to neighboring cells), thereby promoting group cell migration. In Dictyostelium, TORC2 is activated downstream 
from the chemoattractant (cAMP) receptor cAR1, a Ras guanine exchange factor (GEF)-containing complex 
termed Sca1C, and the Ras protein RasC, which is required for cAMP production and the signal relay response5–8.
In addition to the RasC-TORC2 pathway, chemoattractant stimulation induces the activation of several other 
signaling pathways initiated by Ras family GTPases, including RasG and Rap1. RasG is activated, in part, by the 
Ras GEF RasGEFR, and stimulates phosphatidylinositol 3-kinase (PI3K) activity, thereby controlling the site of 
F-actin polymerization and directionality of migration9–12. Rap1 is activated downstream of RasG13, controls 
cell-substrate adhesion and promotes cell polarization by regulating F-actin remodeling, through both PI3K and 
Rac proteins, and by inhibiting myosin assembly at the leading edge, through its effector Phg214–18.
Here, using an unbiased proteomics approach to identify novel regulators of TORC2 in chemotaxis, we dis-
covered that Rap1 binds the TORC2 component RIP3/SIN1, and that, in addition to RasC, Dictyostelium Rap1 
regulates TORC2 activity. Further, we found that this interaction is conserved for human Rap1 and SIN1. Finally, 
we found that Dictyostelium RasC binds the catalytic domain of TOR, which suggests that RasC may regulate 
TORC2 via a mechanism similar to which Rheb regulates TORC119. We propose that the Ras and Rap1 regulation 
of TORC2 promotes the integration of Ras and Rap1 signaling pathways in response to chemoattractants, thereby 
coordinating signal relay with the motility cycle during chemotaxis.
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Results
Rap1 is a conserved binding partner of TORC2 component RIP3/SIN1 whereas RasC binds 
TOR. To identify proteins regulating TORC2 function, we expressed His/Flag-tagged Pianissimo (HF-Pia), 
the Dictyostelium orthologue of mammalian TORC2 essential component Rictor, in piaA null cells, and used 
HF-Pia to purify TORC2 from cells stimulated by the chemoattractant (Fig. 1a). Proteins that co-purify with 
HF-Pia were identified by mass spectrometry. As expected, known components of TORC2, and of protein syn-
thesis and folding complexes co-purify with HF-Pia (see Supplementary Table S1). Of interest, we found that the 
small GTPase Rap1 was specifically pulled-down with HF-Pia (Fig. 1b). In addition, in a pull-down screen that we 
previously performed with recombinant, purified GST-fused Rap1 pre-loaded with non-hydrolyzable GppNHp 
(active state) or GDP (inactive state)16, we found that the TORC2 component RIP3 (orthologue of mammalian 
SIN1) specifically co-purifies with Rap1GppNHp (Fig. 1c). Together with our finding that Rap1 co-purifies with Pia, 
this observation suggests that Rap1 interacts with TORC2 by directly binding RIP3.
Similar to most Ras/Rap effectors, RIP3/SIN1 contains a Ras Binding Domain (RBD)20,21. Despite low amino 
acid sequence conservation, all RBDs have a typical ubiquitin-like fold that facilitates binding to Ras proteins. 
The RBD of RIP3 was previously shown to be important for TORC2 function in Dictyostelium chemotaxis and 
to bind the active form of the Ras protein RasG, and not RasC, in vitro22. However, in vivo, RasC, and not RasG, 
promotes TORC2 activation5,23. To determine if Rap1 directly interacts with the RBD of RIP3 (RIP3RBD), we 
assessed their binding in vitro, compared to the binding of RIP3RBD to other Dictyostelium Ras proteins (RasB, 
RasC, RasD, RasG and RasS). We found that only the active forms of Rap1 and RasG bind RIP3RBD in vitro 
(Fig. 1d). To quantify and compare the binding of RIP3RBD to Rap1 and RasG, we performed a guanine nucleotide 
dissociation (GDI) assay18. Nucleotide dependent binding of an effector to a GTP-bound G protein stabilizes the 
interaction between the G protein and nucleotide. This stabilization results in inhibition of nucleotide dissocia-
tion from the G protein/effector complex. RasG and Rap1 were pre-loaded with fluorescent mGppNHp, and then 
incubated in the presence of excess unlabeled GppNHp with or without RIP3RBD. The exchange of mGppNHP 
for GppNHp was measured by monitoring fluorescence decay. The resulting observed rate constant (kobs) of flu-
orescence decay was then determined as a measure of effector binding. In the presence of 1 μ M RIP3RBD, the kobs 
for mGppNHp dissociation from Rap1 is greatly reduced (kobsRap1 = 5.0 × 10−5 s−1 versus kobsRap1+RIP3 = 1.0 × 10−7 
s−1), whereas a RIP3 RBD mutant that disrupts Ras/Rap1 binding22 (see Supplemental Fig. S1b) has no effect, 
indicating that RIP3 is binding Rap1 with high affinity, and in a nucleotide dependent way (Fig. 1e). On the other 
hand, the presence of 1 μ M RIP3RBD did not inhibit nucleotide exchange on RasG (kobsRasG = 5.9 × 10−5 s−1 and 
kobs RasG+RIP3 = 6.0 × 10−5 s−1). Consequently, the observation that RIP3 binds with high affinity to Rap1GppNHp sug-
gests RIP3 is a Rap1 effector, whereas the lack of high binding affinity of RIP3 for RasGGppNHp suggests RIP3 is not 
likely an effector of RasG, which is consistent with previous in vivo studies23. We then asked if Rap1 binding tRIP3 
is conserved in mammals by assessing the interaction of human Rap1b to SIN1RBD using purified proteins in vitro. 
We observed that SIN1RBD binds GppNHp-loaded Rap1b and not nucleotide free Rap1b (Fig. 1f). Therefore, our 
findings suggest that active Rap1 binds TORC2 through the TORC2-specific subunit RIP3/SIN1, and that this 
interaction is conserved in mammals.
Although others and we have clear evidence that RasC promotes TORC2 activation in response to chemoat-
tractant stimulation in Dictyostelium (present study)5,6, we find that, unlike Rap1, RasC does not bind RIP3 
(Fig. 1d). However, a constitutively active RasC mutant was reported to co-purify with RIP36, suggesting a pos-
sible indirect interaction. Interestingly, in a screen for potential RasC-interacting proteins, performed using a 
protocol similar to that described to identify Rap1-interacting proteins in Fig. 1c, we found that TOR kinase itself 
specifically co-purifies with RasCGppNHp (Fig. 1g). We verified that RasC binds directly to TOR using recombi-
nant, purified proteins in vitro. We observed that active RasC, using either GppNHp-loaded or a constitutively 
active RasC mutant, binds the catalytic domain of TOR [FKBP-Rapamycin Binding (FRB)/kinase domain] with 
an average of 9 ± 3.3% efficiency in vitro, whereas no binding was observed with inactive, GDP-loaded RasC or a 
constitutively active Rap1 mutant (Fig. 1h and Supplementary Fig. S3). Thus, together with previous observations, 
these results suggest that RasC activates TORC2 by directly regulating TOR kinase.
Rap1 regulates the RasC-mediated activation of TORC2. To assess whether Rap1, in addition to 
RasC, can induce TORC2 activation, we first examined the ability of purified, recombinant Rap1, loaded with 
GppNHp, to induce TORC2 activation in cell lysates. We monitored TORC2 activation by evaluating its phos-
phorylation of Akt/Protein Kinase B (PKB) and related kinase PKBR1 hydrophobic motif (TP435 and TP470, 
respectively)5,7,23. Consistent with previous findings5,6, RasCGppNHp stimulation of wild-type cell lysates induces 
the TORC2-mediated phosphorylation of both PKB (~50 kDa band) and PKBR1 (~70 kDa band) (Fig. 2). 
Interestingly, we found that Rap1GppNHp also stimulates PKBR1 T470 phosphorylation in cell lysates, suggesting 
activation of TORC2. We do not know why Rap1GppNHp stimulation of cell lysates induces PKBR1 phosphoryla-
tion and not that of PKB, but this may suggest an involvement of Rap1 in TORC2 substrate selection and will be 
the subject of future investigations. Rap1GppNHp and RasCGppNHp do not induce PKBR1 phosphorylation in piaA 
null cell lysates (see Supplementary Fig. S4), confirming that the observed responses are mediated by TORC2. 
Further, RasGGppNHp, RasCGDP, and Rap1GDP fail to promote TORC2 activation in wild-type cell lysates, indicating 
that only active RasC and Rap1, and not RasG, can promote TORC2 activation.
As cells lacking Rap1 are not viable, to test whether Rap1 controls TORC2 activity in vivo, we compared the 
chemoattractant-induced TORC2 activation in wild-type cells to that in cells displaying elevated Rap1 activity 
either by overexpressing wild-type Rap1 (Rap1OE), expressing a constitutively active Rap1 mutant (Rap1CA, G12V 
mutation), or in cells lacking one of the Rap1-specific GAP, RapGAP1 (rapgap1 null), in which Rap1 activity 
is considerably elevated14,24 (see Supplementary Fig. S6a). In this assay, PKB T435 phosphorylation is some-
times difficult to detect, but PKBR1 T470 phosphorylation is easily traced. As shown in Fig. 3a, we reproducibly 
observed elevated and extended chemoattractant-induced PKBR1 phosphorylation in all three conditions tested 
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Figure 1. TORC2 binds RasC and Rap1 through different complex components. (a) Developed piaA null 
cells expressing HF-Pia were stimulated with the chemoattractant (10 μ M cAMP) for 10 sec, followed by 
sequential His-Flag purification. Proteins pulled-down with HF-Pia were resolved by SDS-PAGE and stained 
with silver. Wild-type cells were used as control. (b) Mass spectrometry data identifying Rap1 co-purifying 
with HF-Pia. The full list of proteins identified in the HF-Pia pull-down is available in Supplementary Table 
S1. (c) Mass spectrometry data identifying RIP3 in the pull-down performed with GST-Rap1GppNHp. (d) 
Interaction between GST-RIP3RBD and His-tagged Rap1, RasG, RasB, RasC, RasD, and RasS was assessed 
using recombinant, purified proteins in vitro, comparing the binding of constitutively active (CA) and 
GDP-bound (inactive) Rap1/Ras proteins. His-Rap1/Ras proteins were detected by immunoblotting. 
Immunoblots were cropped, but no other bands were present. Amount of Ras/Rap1 proteins used is shown 
in Supplementary Fig. S1a. (e) Dissociation of mGppNHp from Rap1 and RasG was measured in the 
presence and absence of 1 μ M RIP3RBD or RIP3(K680E, R681E)RBD. (f) Interaction between GST-SIN1RBD and 
His-tagged GppNHp-bound or nucleotide free (EDTA) human Rap1b was assessed using recombinant, 
purified proteins in vitro. His-peptide was used as control. Loadings are equivalent between the input and 
His-Pull-down conditions. Band at ~24 kDa in GST-SIN1RBD input corresponds to free GST. Pull-down 
proteins were revealed by Commassie Blue (CB) staining. (g) Mass spectrometry data identifying TOR in the 
pull-down performed with GST-RasCGppNHp. (h) The interaction between GFP-fused TOR catalytic domain 
(FRB/KinTOR) and GST-fused GppNHp- or GDP-bound RasC was assessed using recombinant, purified 
proteins in vitro. GFP-FRB/KinTOR and GST-RasC were revealed by immunoblotting. Input represent 33% 
of protein used in assay. Uncropped gel and immmunoblots are shown in Supplementary Fig. S2. Data are 
representative of at least two independent experiments.
www.nature.com/scientificreports/
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where Rap1 activity is elevated compared to that in wild-type cells. Although the extent of the effect of Rap1CA on 
PKBR1 phosphorylation varied between experiments, likely due to varying levels of Rap1CA expression related 
to plasmid copy number per cell as was previously described25–27, quantification of the data nonetheless revealed 
significant (at 40 and 60 sec) or near-significant effects (5 sec, p = 0.053; 10 sec, p = 0.084; 20 sec, p = 0.077). For 
Rap1OE and rapgap1 null cells, the effects are strongly significant (for 10 and 20 sec time points, p is between 
0.0003 and 0.004). Consistent with an increase in TORC2-mediated PKBR1 phosphorylation, PKBR1 kinase 
activity is also prolonged in Rap1CA, Rap1OE, and rapgap1 null cells, although the effect is not as pronounced as 
that on PKBR1 T470 phosphorylation (Fig. 3b). This difference is likely due to the fact that the PKB kinase activity 
is not only regulated by TORC2 but also by other chemotactic effectors and regulatory mechanisms (e.g. GSK3, 
Protein Phosphatase 2A28,29).
The increase in PKBR1 phosphorylation observed in rapgap1 null, and in Rap1CA and Rap1OE cells is not 
observed in rapgap1/ripA double null cells or ripA null cells expressing Rap1CA or Rap1OE, nor is there any 
TORC2-mediated PKBR1 phosphorylation observed in ripA null cells expressing the RIP3(K680E,R681E) mutant 
(Fig. 3c). These observations indicate that Rap1 interaction with RIP3 is necessary for the observed effect of 
elevated Rap1 activity on TORC2-mediated PKBR1 phosphorylation and, thus, that Rap1 plays an impor-
tant role in controlling TORC2 activation. Of note, we sometimes detect constitutive PKB phosphorylation in 
ripA null cells (Fig. 3c and Supplementary Fig. S6b), as was previously observed7, but the meaning of which is 
unknown. Interestingly, however, neither Rap1OE nor Rap1CA induce PKBR1 phosphorylation in cells lacking 
RasC, suggesting that RasC is essential for TORC2 activation and the Rap1-mediated effect on TORC2 (Fig. 3d). 
Consequently, we propose that Rap1 positively regulates the RasC-mediated activation of TORC2 in response to 
chemoattractants.
Discussion
Our findings reveal new, and likely conserved, mechanisms by which Dictyostelium TORC2 is regulated, where 
both RasC and Rap1 control TORC2 activity through binding of distinct TORC2 components, TOR and RIP3/
SIN1, respectively (Fig. 4). In addition, our findings suggest that RasC plays a major role in TORC2 activation and 
that Rap1 regulates the RasC-mediated activation of TORC2. Whereas we can’t exclude the possibility that Rap1 
binds RIP3/SIN1 independently of TORC2, the observation that Rap1 co-purifies with the TORC2 component 
Pia/Rictor strongly suggests Rap1 binds the TORC2-associated RIP3/SIN1 and, thereby, directly interacts with 
TORC2. The finding that RasC binds to the catalytic domain of TOR is particularly interesting as it indicates 
that RasC may activate TORC2 using a mechanism that is similar to the reported Rheb-mediated activation of 
mTORC119, and that RasC may regulate TORC1 as well. Moreover, as human H-Ras was reported to co-purify 
with mTORC221, we believe that Ras binding to TOR is likely conserved in mammals. Unfortunately, we were 
unable to test direct binding of human H-Ras to mTOR in vitro due to the difficulty to obtain stable, recombinant 
mTOR constructs.
Other proteins that we found associated with Dictyostelium TORC2 that are known to or could play a role in 
regulating TORC2 function in chemotaxis include Rac1A and Rab small GTPases, as well as the actin nucleator 
Formin A. TORC2 interaction with Formin A could represent a potential link between TORC2 and F-actin. In 
mammals, Rac1 binds TOR and mediates TORC1 and TORC2 localization to specific membranes30, and in fis-
sion yeast, a Rab-family GTPase was shown to bind and regulate TORC2 signaling31. Therefore, our finding that 
Rac1A and two Rab GTPases, Rab11A and RabC, bind TORC2 suggests that the role of these small GTPases in 
regulating TORC2 may be conserved in Dictyostelium. Finally, although the identification of ribosomal proteins 
in our HF-Pia pull-down is expected, as HF-Pia was exogenously over-expressed, it is possible that the binding of 
Figure 2. Active RasC and Rap1 both induce TORC2 activation in cell lysates. Cell lysates were stimulated 
with recombinant, purified, GppNHp- or GDP-bound RasC, Rap1, and RasG for the indicated time. 
Phosphorylation of PKB (TP435; ~50 kDa) and PKBR1 (TP470; ~70 kDa) was detected by immunoblotting as 
a measure of TORC2 activation. Data are representative of at least two independent experiments. Uncropped 
immunoblots are shown in Supplementary Fig. S5.
www.nature.com/scientificreports/
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Figure 3. Rap1 positively regulates the RasC-mediated activation of TORC2. (a,c,d) TORC2 
phosphorylation of PKB (TP435) and PKBR1 (TP470) was assessed in wild-type cells (WT), in cells lacking 
RapGAP1 (rapgap1−), RIP3 (ripA−), both RIP3 and RapGAP1 (rapgap1−ripA−), or RasC (rasC−), and in 
wild-type, ripA−, and rasC− cells expressing tagged Rap1CA or Rap1OE, and in ripA− cells expressing either 
wild-type T7-RIP3 or T7-RIP3(K680E,681E). Cells were stimulated with 10 μ M cAMP for the indicated time. PKB/
PKBR1 phosphorylation and expression of exogenous Rap1, Rap1CA, RIP3, and RIP3(K680E,681E) were revealed 
www.nature.com/scientificreports/
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ribosomal proteins to HF-Pia represents a functional interaction. Indeed, some TORC2 functions were shown to 
require its association with ribosomes in both yeasts and mammals32,33.
We propose that the dual RasC- and Rap1-mediated regulation of TORC2 in Dictyostelium allows for integra-
tion of RasC and Rap1 signaling pathways during chemotaxis and, thereby, coordination of cytoskeletal remod-
eling, substrate adhesion, and relay of the chemoattractant signal to neighboring cells (Fig. 4). The organized 
migration of groups of cells is crucial to Dictyostelium and human embryonic development as well as to wound 
healing, and is also involved in cancer metastasis34–39. For cells to achieve collective migration as a cohesive group, 
they must synchronize their movement, which is achieved through cell-cell communication such as signal relay 
during chemotaxis. Our findings place TORC2 in an ideal position to promote the coordinated regulation of 
these processes and control group cell migration. Since the interactions between TORC2 and Ras/Rap1 appear 
conserved, we suggest TORC2 integrates these signals to coordinate cellular migrations in many systems.
Methods
Reagents and antibodies. cAMP sodium salt monohydrate was from Sigma-Aldrich (St. Louis, MO, 
USA) and H2B was from Roche-Genentech (San Francisco, CA, USA). Anti-myc (Myc A7) was from Abcam 
(Cambridge, MA, USA), anti-Pan Ras (Ab-3; RAS10) was from Calbiochem/EMD Millipore (Billerica, MA, 
USA), anti-GFP was from Covance (Princeton, NJ, USA), horseradish peroxidase-conjugated secondary anti-
bodies were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA, USA), and DyLightTM 
secondary antibodies were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Anti-GFP, anti-GST, 
protein-A sepharose, and GSH affinity resin were from GE Healthcare (Pittsburgh, PA, USA). DdPKBR1 anti-
body was described previously40.
DNA constructs. His-Flag-Pianissimo (HF-Pia) was generated by adding 6XHis and Flag tags, in tandem, 
by PCR to the N-terminus of Pia’s coding sequence, which was cloned in the pDM304 vector containing a neo-
mycin resistance cassette. Myc-tagged constitutively active Rap1 (Myc-Rap1CA; G12V mutation) obtained from 
Rick Firtel14 was transferred to the pDM358 vector containing a hygromycin resistance cassette. FRB/KinTOR (aa 
1820–2380) was amplified by PCR and subsequently cloned in the pDM317 vector containing N-terminal GFP 
and neomycin resistance cassette. The RIP3RBD (aa 648–717) used in the in vitro binding assay (Fig. 1d), and 
RasC, were expressed as N-terminal GST-fusion from a pGEX-4T-1 vector. Constitutively active RasC (RasCCA, 
G62L mutation) was generated by the method of Quick change. 6XHis-tagged wild-type and constitutively active 
forms of the Rap1 and Ras proteins were described previously41. The RIP3RBD (aa 511–838) and SIN1RBD (aa 
266–374), used in the GDI experiment (Fig. 1e) and in vitro binding assay (Fig. 1f), respectively, were expressed 
as N-terminal GST-fusion from a pGEX-4T-3 plasmid. His-Rap1b was a kind gift of Alfred Wittinghofer.
Cell culture and strains used. Dictyostelium cells were grown in axenic HL5 medium (ForMedium, 
Hunstanton, Norfolk, UK) at 22 °C and transformants were generated by electroporation. Transformed cells were 
selected in 20 μ g/ml Geneticin or 50 μ g/ml Hygromycin B (both from Life Technologies, Grand Island, NY, USA) 
and expression confirmed by immunoblotting. Aggregation-competent cells were obtained by pulsing cells with 
30 nM cAMP every 6 min for 5.5h in 12 mM Na/K phosphate pH 6.1 at 5 × 106 cells/ml. Wild-type cells are AX3 
and all transformants and null strains have an AX3 background. gbpD null cells were described elsewhere18, piaA 
null and rapgap1 null cells were provided by Peter Devreotes and Rick Firtel, respectively, and were previously 
described24,42. The rapgap1/ripA double null strain was generated by disrupting ripA in the rapgap1 null back-
ground, as described previously43.
Pull-downs and mass spectrometry. Sequential His-Flag purification and identification of the isolated 
proteins by mass spectrometry was performed as previously described5. The pull-down screens for RasC and 
Rap1 effectors were performed as previously described16,44.
In vitro binding studies. GST-fused RIP3RBD, -SIN1RBD, -Rap1, and -RasC were purified by GSH affinity 
and size exclusion chromatography as previously described18,45. Purification of His-tagged Rap1 and Ras pro-
teins, and the in vitro interaction assay with RIP3RBD was performed as described previously41. Purified proteins’ 
quality was verified on gel and quantified (see Supplemental Fig. S1), and equal amounts were used for each 
interaction assessed. His-Rap1/Ras proteins were detected by immunoblotting with anti-His monoclonal anti-
body (sc-8036; Santa Cruz Biotechnology, Dallas, TX, USA). Interaction between His-tagged GppNHp-bound or 
nucleotide free (EDTA) human Rap1b and GST-SIN1RBD was tested using 25 μ g of the purified proteins incubated 
in binding buffer (50 mM Tris-Cl, 150 mM NaCl, 5 mM MgCl2, 1 mM β -mercaptoethanol, pH 7.5), and proteins 
were pulled-down with Ni-NTA affinity resin (Qiagen, Valencia, CA, USA) for 2 hours at 4 °C. The beads were 
washed three times with ice-cold binding buffer containing 500 mM NaCl, and eluted with 300 mM imidazole in 
binding buffer. The proteins were resolved on SDS-PAGE and revealed by Coomassie Blue staining. GFP-FRB/
KinTOR was isolated from Dictyostelium cell lysates using anti-GFP antibody coupled to protein A Sepharose 
by immunoblotting. Equal loading was controlled with Coomassie Blue staining (CB). (b) cAMP-induced 
kinase activity of immunoprecipitated PKBR1 was assessed in the indicated strains using H2B as substrate. H2B 
phosphorylation was detected by autoradiography and PKBR1 revealed by immunoblotting. Graphs represent 
mean ± SEM of densitometry quantification data of immunoblots or autoradiographs, from at least three 
independent experiments, expressed as % of the maximal signal detected in wild-type control cells. *p < 0.05, 
**p < 0.01, ***p < 0.005. Uncropped immunoblots and autoradiographs are shown in Supplementary Fig. S7.
www.nature.com/scientificreports/
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beads. Interaction between GFP-FRB/KinTOR and GST-fused GppNHp- or GDP-loaded RasC was tested using 
25 μ g of the purified proteins incubated in binding buffer (50 mM Tris-Cl, 150 mM NaCl, 5 mM MgCl2, 1 mM 
β -mercaptoethanol, pH 7.5), and proteins were pulled-down with GSH affinity resin. The beads were washed 
three times with ice-cold binding buffer containing 500 mM NaCl, and eluted with 20 mM glutathione in binding 
buffer. The proteins were resolved on SDS-PAGE and revealed by GFP and GST immunoblotting.
Biochemical assays. The guanine nucleotide dissociation inhibition (GDI) assay, Rap1 activity assay, and 
PKBR1 kinase assay were performed as previously described14,18,40. To test the ability of Rap1, RasC or RasG 
to activate TORC2 in cell lysates, the GTPases were loaded with GDP or GppNHp as previously described18. 
Aggregation competent wild-type cells were harvested by centrifugation and re-suspended in buffer contain-
ing 50 mM Tris-Cl (pH = 7.5), 150 mM NaCl, 5 mM MgCl2, 5 mM DTT, 5% Glycerol. Cells were lysed on 5 μ m 
Nuclepore filter and the lysate was cleared by 16,000 × g centrifugation for 5 min at 4 °C. Total cell lysate protein 
content and purified Ras/Rap1 were quantified with Bradford reagent and 400 μ g of cell lysate was stimulated with 
1 μ M of nucleotide bound GTPases and samples collected at the indicated times. 50 μ g of proteins were loaded on 
gel for each sample. TORC2 activity was assessed by evaluating the TORC2-mediated phosphorylation of PKB 
and PKBR1 as described previously5, with the exception that an anti-phospho-p70S6K antibody (Cell Signaling 
Technology, Danvers, MA, USA) was used to detect phosphorylation of PKB/PKBR1’s hydrophobic motif (TP435 
and TP470, respectively). Significance of the data was analyzed using unpaired T-Test.
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